相关实验视频

Updated: Jan 13, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

机器学习预测甲状腺癌复发的早期查和临床决策途径:一个回顾性队列研究

Guobin Hu¹, Bin Huang², Li Cai³

¹The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.

Discover oncology

|January 7, 2026

概括

机器学习模型准确地预测差异化甲状腺癌 (DTC) 复发,使用关键特征,如风险,N阶段,T阶段和年龄. 简化模型保持高准确度,有助于个性化患者监测和治疗决策.

科学领域:

在瘤学瘤学.
医疗信息学医疗信息学
机器学习机器学习

背景情况:

差异化甲状腺癌 (DTC) 复发预测具有挑战性.
早期识别高风险患者可以改善监测和治疗.
机器学习 (ML) 为改善风险分层提供了潜力.

研究的目的:

用临床病理学特征评估DTC复发预测的ML模型.
评估简化特征集对模型可解释性和性能的有用性.
确定用于增强临床决策的关键预测因素.

主要方法:

在383名DTC患者的队列中开发了随机森林,XGBoost和LightGBM模型.
使用分层抽样,SMOTE,交叉验证和概率校准.
应用SHAP分析来确定特征的重要性和缩小维度.

主要成果:

全功能模型表现出强的性能 (随机森林的最高AUC为0.931).
一个简化的4个特征模型 (风险,N,T,年龄) 实现了高精度 (AUC 0.913).
SHAP分析证实了风险,N,T和年龄作为主要预测因素.

结论:

精简,可解释的ML模型可以准确预测DTC复发.
简化的模型提供了计算效率和现实世界的部署性.
这些模型支持将其整合到临床工作流程中,以实现个性化的患者护理.

关键词:

临床决策支持临床决策支持机器学习是机器学习.预测复发的预测.差异化良好的甲状腺癌

更多相关视频

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

相关概念视频

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...